Medical comorbidities predict mortality in women with a history of early stage breast cancer

By Patterson Ruth  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 859-865

Springer Publishing Company

Access to resources Recommend Favorite

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers. Letsch M, Schally AV, Busto R, Bajo AM, Varga JL, Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, and Section of Experimental Medicine, Department of Medicine, Tulane University School of Medicine, New Orleans, LA - Proc Natl Acad Sci USA 2003;100:1250-1255

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 411-412

Elsevier

Access to resources Recommend Favorite

Data mining with decision trees for diagnosis of breast tumor in medical ultrasonic images

By Kuo W-J.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 1, 2001-03 ,pp. : 51-57

Springer Publishing Company

Access to resources Recommend Favorite

Surgical prophylaxis in familial adenomatous polyposis: do pre-existing desmoids outside the abdominal cavity matter?

By Sinha Ashish   Gibbons Daniel   Phillips Robin   Clark Sue  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 407-411

Springer Publishing Company

Access to resources Recommend Favorite

Bilateral Mucoepidermoid Carcinomas Arising in Bilateral Pre-existing Warthin's Tumours of the Parotid Gland

By Seifert G.  

European Journal of Cancer. Part B: Oral Oncology, Vol. 33, Iss. 4, 1997-07 ,pp. : 284-287

Elsevier

Access to resources Recommend Favorite